1.
Reboxetine depression research
Reboxetine is a NorAdrenaline Reuptake Inhibitor (NARI) that is approved in over 50 countries as an antidepressant. In May 2001, the FDA declined the ...
2.
Reboxetine depression research
reboxetine information and depression research. ... Reboxetine effects on Hamilton Depression Rating Scale 13. Reboxetine comparison with fluoxetine ...
3.
Reboxetine, stimulant effects in patients with narcolepsy
CONCLUSIONS: Our results suggest that reboxetine exerts stimulant and anticataplectic effects in narcolepsy. Contrary to previous thinking, ...
4.
5.
6.
7.
8.
9.
10.